Farmabios SPA

Axplora announces the appointment of its Scientific Advisory Board

13 Nov 2023

// PRESS RELEASE

Farmabios, an Axplora company, granted cGMP approval from AIFA for extended production capacity in HPAPIs and Steroids

10 Oct 2023

// PRESS RELEASE

Novo bets $600M on NanoVation's ability to take genetic medicines beyond liver

19 Sep 2024

// Nick Paul FIERCE BIOTECH

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

BioProcess International

Not Confirmed

Book a meeting

envelop Contact Supplier

DIGITAL CONTENT

2 NEWS #PharmaBuzz

media
2 NEWS #PharmaBuzz

About

Axplora, created from the merger of Farmabios, Novasep & PharmaZell, is a leading API manufacturing partner to the world’s leading pharma & biotech companies, delivering top-quality APIs on time & at scale, to the highest industry standards. It is dedicated to helping pharma companies make critical medicines safely to benefit patients. Leveraging our combined expertise & manufacturing capabilities across 9 industrial sites in the EU & India & an R&D facility in the USA, it offers CDMO services for small molecule APIs & biopharmaceuticals to innovators as well as APIs that address lifestyle-induced respiratory, inflammatory & liver diseases.